Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 14.16 is in line with its 4-year average of 15.36, around the middle of its 4-year range (0.00–32.82).
As of the fiscal period ended Tuesday, June 30, 2026. 3.22% above its 12-month average of 13.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.16.
CURRENT RATIO
14.16
CURRENT RATIO AVG TTM
13.72
CURRENT RATIO AVG 3Y
14.77
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.22%
CURRENT VS 3Y AVG
-4.13%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 571 covered companies
CURRENT VS SECTOR MEDIAN
+322.58%
vs the sector median at left
ArriVent BioPharma, Inc.
Market Cap
$1.33B
Current Ratio
14.16
TTM Avg
13.72
3Y Avg
14.77
5Y Avg
N/A
Market Cap
$1.34B
Current Ratio
35.85
TTM Avg
18.03
3Y Avg
18.03
5Y Avg
18.03
Market Cap
$1.35B
Current Ratio
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | $1.33B | 14.16 | 13.72 | 14.77 | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | 11.09 | 7.43 | 12.87 | 13.60 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.34B | 35.85 | 18.03 | 18.03 | 18.03 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.35B | 11.11 | 12.01 | 12.01 | 12.01 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | 5.07 | 3.94 | 5.82 | 5.62 |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 5.61 | 9.29 | 11.65 | 16.84 |
| Kardigan, Inc. (KARD)vs › | $1.22B | 8.72 | 9.20 | 9.20 | 9.20 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 16.18 | 19.21 | 18.77 | 16.93 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 1.05 | 1.06 | 1.16 | 1.68 |
| MannKind Corporation (MNKD)vs › | $1.21B | 1.72 | 2.49 | 3.01 | 2.95 |
Current Ratio
14.16
Quick Ratio
14.16
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 14.16 |
| 2026-03-31 | 13.95 |
| 2025-12-31 | 12.83 |
| 2025-09-30 | 14.90 |
| 2025-06-30 | 12.74 |
| 2025-03-31 | 14.34 |
| 2024-12-31 | 13.14 |
| 2024-09-30 | 19.28 |
| 2024-06-30 | 25.50 |
| 2024-03-31 | 32.82 |
| 2023-12-31 | 13.76 |
| 2023-09-30 | 17.82 |
| 2023-06-30 | 15.51 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 21.84 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
